Stay updated with breaking news from Tilmann Bur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teltow (pta011/28.03.2022/10:00) - Teltow / Leipzig, 28 March 2022 – CO.DON AG’s product was included on the Belgian list of medicinal products eligible for reimbursement as of 1 April 2022. It had previously received a positive cost-benefit assessment from the Belgian institute for health and invalidity insurance INAMI, which was endorsed by the ministry responsible.
Teltow / Leipzig, 21 March 2022 - CO.DON AG and JOINT OPERATIONS LLP signed an exclusive agreement to distribute the EU-authorised, cell-based medicinal product Spherox in the United Kingdom,... | March 21, 2022
Teltow / Leipzig 1 March 2021 - CO.DON AG has received the final assessment from the European Medicines Agency's Committee for Medicinal Products for Human Use for its pharmaceutical product... | March 1, 2022
PTA-News: CO.DON AG: EU-approved medicinal product receives vote for indication extension for use in adolescents 5/25, 10:00 AM (Source: pressetext) Teltow (pta020/25.05.2021/10:00) - Teltow / Leipzig, 25 May 2021 - CO.DON AG received at the end of last week (see adhoc announcement of 21 May 2021) the positive vote of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). on the approval of the application for indication extension of the EU-approved medicinal product for human use for use in adolescents. Business news for the stoc...